
LSMU & KELI Therapeutics
Justinas Mačiulaitis, PhD
CEO @ KELI Therapeutics,
Investigator @ Lithuanian University of Health Sciences
Topic: Cell-based Therapeutics Development: from Idea to the Patient
The intersection of medicine, biology, pharmaceuticals, and biotechnology represents a dynamic field for innovations.
There is a constant and focused effort to transform laboratory challenges into tangible medical treatments that reach the patient.
Innovative solutions such as cells and exosomes are developed for acute conditions such as kidney injuries, illustrating strategies to manage these conditions.
Additionally, the advancement of treatments for debilitating chronic diseases, such as degenerative joint and skin conditions aim to enhance patient quality of life and longevity.
These developments play a crucial role in improving overall health and wellness, marking a pivotal shift from ideas to impactful patient care.
-
-
R106
Cell-based Therapeutics Development: from Idea to the Patient
Justinas Mačiulaitis, PhD (KELI Therapeutics and Lithuanian University of Health Sciences)
-